GB1193192A - Pharmaceutical Compositions - Google Patents
Pharmaceutical CompositionsInfo
- Publication number
- GB1193192A GB1193192A GB08102/67A GB1810267A GB1193192A GB 1193192 A GB1193192 A GB 1193192A GB 08102/67 A GB08102/67 A GB 08102/67A GB 1810267 A GB1810267 A GB 1810267A GB 1193192 A GB1193192 A GB 1193192A
- Authority
- GB
- United Kingdom
- Prior art keywords
- carboxylic acid
- uracil
- compositions
- methionine
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000005907 alkyl ester group Chemical group 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- CXJHFMMYWITJGH-YFKPBYRVSA-N (2S)-2-(methoxyamino)-4-methylsulfanylbutanoic acid Chemical compound CON[C@@H](CCSC)C(=O)O CXJHFMMYWITJGH-YFKPBYRVSA-N 0.000 abstract 1
- KFSJYZYQSZKRRQ-BYPYZUCNSA-N (2s)-2-(hydroxyamino)-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@H](NO)C(O)=O KFSJYZYQSZKRRQ-BYPYZUCNSA-N 0.000 abstract 1
- RVCLISIPGZGQPU-UHFFFAOYSA-N 2,6-dichloro-3-chlorosulfonylbenzoic acid Chemical compound OC(=O)C1=C(Cl)C=CC(S(Cl)(=O)=O)=C1Cl RVCLISIPGZGQPU-UHFFFAOYSA-N 0.000 abstract 1
- ISOQUWRYYNKKGX-UHFFFAOYSA-N 4-oxo-2-sulfanylidene-1h-pyrimidine-6-carboxylic acid Chemical group OC(=O)C1=CC(O)=NC(S)=N1 ISOQUWRYYNKKGX-UHFFFAOYSA-N 0.000 abstract 1
- 229940105150 5-methyltetrahydrofolic acid Drugs 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 239000004381 Choline salt Substances 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 230000000719 anti-leukaemic effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 235000019417 choline salt Nutrition 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000012022 methylating agents Substances 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 150000003248 quinolines Chemical class 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- ZXYAAVBXHKCJJB-UHFFFAOYSA-N uracil-5-carboxylic acid Chemical compound OC(=O)C1=CNC(=O)NC1=O ZXYAAVBXHKCJJB-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08102/67A GB1193192A (en) | 1967-04-19 | 1967-04-19 | Pharmaceutical Compositions |
| US722183A US3608079A (en) | 1967-04-19 | 1968-04-18 | Thiouracil-carboxylic acids for treatment of viruses |
| NL686805514A NL140733B (nl) | 1967-04-19 | 1968-04-18 | Werkwijze ter bereiding van een farmaceutisch of voedingspreparaat in eenheidsdoseringsvorm. |
| BE713858D BE713858A (cg-RX-API-DMAC10.html) | 1967-04-19 | 1968-04-18 | |
| DE1767275A DE1767275C3 (de) | 1967-04-19 | 1968-04-19 | Verwendung von 2-Thio-4-uracilcarbonsäure und 4-Uracilcarbonsäure |
| FR148634A FR7478M (cg-RX-API-DMAC10.html) | 1967-04-19 | 1968-04-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08102/67A GB1193192A (en) | 1967-04-19 | 1967-04-19 | Pharmaceutical Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1193192A true GB1193192A (en) | 1970-05-28 |
Family
ID=10106685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08102/67A Expired GB1193192A (en) | 1967-04-19 | 1967-04-19 | Pharmaceutical Compositions |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3608079A (cg-RX-API-DMAC10.html) |
| BE (1) | BE713858A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1767275C3 (cg-RX-API-DMAC10.html) |
| FR (1) | FR7478M (cg-RX-API-DMAC10.html) |
| GB (1) | GB1193192A (cg-RX-API-DMAC10.html) |
| NL (1) | NL140733B (cg-RX-API-DMAC10.html) |
-
1967
- 1967-04-19 GB GB08102/67A patent/GB1193192A/en not_active Expired
-
1968
- 1968-04-18 BE BE713858D patent/BE713858A/xx not_active IP Right Cessation
- 1968-04-18 US US722183A patent/US3608079A/en not_active Expired - Lifetime
- 1968-04-18 NL NL686805514A patent/NL140733B/xx unknown
- 1968-04-19 FR FR148634A patent/FR7478M/fr not_active Expired
- 1968-04-19 DE DE1767275A patent/DE1767275C3/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1767275C3 (de) | 1979-06-21 |
| FR7478M (cg-RX-API-DMAC10.html) | 1969-12-01 |
| NL140733B (nl) | 1974-01-15 |
| DE1767275B2 (de) | 1978-10-26 |
| US3608079A (en) | 1971-09-21 |
| NL6805514A (cg-RX-API-DMAC10.html) | 1968-10-21 |
| BE713858A (cg-RX-API-DMAC10.html) | 1968-10-18 |
| DE1767275A1 (de) | 1972-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1193192A (en) | Pharmaceutical Compositions | |
| ES375203A1 (es) | Un procedimiento para preparar un derivado de benzotiazepi-na. | |
| GB1097531A (en) | Improvements in or relating to the preparation of cyclopentane derivatives | |
| GB1188364A (en) | Quinoline Derivatives | |
| GB1252286A (cg-RX-API-DMAC10.html) | ||
| GB1153640A (en) | A Carnitin Salt | |
| GB1193191A (en) | Veterinary Compositions | |
| IE33371L (en) | Protozoacids; aminoguanidine derivatives | |
| GB1145623A (en) | Pharmaceutical composition | |
| GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
| GB1168801A (en) | Quinoline Derivatives | |
| GB1174988A (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
| GB1435923A (en) | Pharmaceutical compositions for treating vascular diseases | |
| GB1166793A (en) | Substituted Benzamides | |
| GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
| GB1168105A (en) | Quinoline Derivatives | |
| GB1046731A (en) | Uracil derivatives in the treatment of avian leukosis | |
| GB1280244A (en) | Serum triglyceride-lowering compositions | |
| GB1417323A (en) | Physiologically active xanthine compounds and compositions containing them | |
| GB1152637A (en) | Veterinary Compositions | |
| GB905197A (en) | Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives | |
| GB1211307A (en) | Aminopropanediol derivatives and compositions containing them | |
| GB1188365A (en) | Quinoline Derivatives | |
| GB1193521A (en) | Novel Esters of 1-Phenyl-1-Benzyl-2-Methyl-3-Dimethylaminopropanol, the preparation thereof and Compositions containing the same | |
| FR1604555A (en) | Antiviral preparations containing elanolic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |